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Abstract
Objectives: Chronic rhinosinusitis (CRS) is a chronic inflammatory disease of the nasal mucosa.
Recent studies suggest that S. aureus enterotoxins may play an etiologic role in the development of
CRS. Apart from surgery and repeated courses of steroids, macrolide antibiotics have been
reported to exert anti-inflammatory effects in CRS. Similar effects have been reported for
fluoroquinolones on various cell types. Since these effects have poorly been characterized in CRS,
we examined anti-inflammatory effects of ciprofloxacin on human nasal epithelial cells (HNECs).
Methods:  Inflammation was induced in HNECs cultured from nasal turbinate mucosa with
supernatants of S. aureus Newman for 12 hours. Subsequently, HNECs were coincubated with S.
aureus Newman and ciprofloxacin (1.5 × 10-5 M), clarithromycin (10-6 M) or prednisolone (10-5 M)
for another 12 hours. IL-8 synthesis was quantified after 12 and 24 hours by ELISA.
Results: Stimulation with S. aureus Newman supernatants was associated with an increase of IL-8
synthesis after 12 hours in all experiments. During the second 12 hours, IL-8 synthesis decreased
and this effect was independent from any stimulus or inhibitor. However, coincubation of HNECs
with ciprofloxacin was associated with a more extensive decrease of IL-8 synthesis. Similarly,
addition of clarithromycin was associated with a reduction of IL-8 synthesis although this effect was
not significant. Coincubation with prednisolone resulted in a significant reduction of IL-8 levels.
Conclusion: Ciprofloxacin exerts anti-inflammatory effects in S. aureus Newman driven nasal
inflammation. Inhibitory effects were comparable to those of prednisolone and clarithromycin.
Introduction
Chronic rhinosinusitis (CRS) is an inflammatory disease
of the nasal and paranasal mucosa that can broadly be
classified in two major forms depending on the presence
(CRSwNP) or absence of nasal polyps (CRSsNP) [1].
Recent studies suggest that S. aureus enterotoxins may play
an etiologic role in the development of CRSwNP [2]. Ther-
apy of CRSwNP often consists of repeated surgical reduc-
tion of nasal polyps and application of steroids. However,
application of topical steroids even over several months
often cannot prevent disease reoccurrence especially in
CRSwNP. This may be due to the unknown underlying
chronic inflammatory process and the phenomenon of
steroid resistance that has also been demonstrated for
Published: 29 July 2008
Journal of Inflammation 2008, 5:11 doi:10.1186/1476-9255-5-11
Received: 21 February 2008
Accepted: 29 July 2008
This article is available from: http://www.journal-inflammation.com/content/5/1/11
© 2008 Sachse et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Inflammation 2008, 5:11 http://www.journal-inflammation.com/content/5/1/11
Page 2 of 6
(page number not for citation purposes)
nasal mucosa [3]. Consequently, alternative anti-inflam-
matory drugs that possess the potential to influence the
chronic inflammatory process in CRSwNP are warranted.
Macrolide antibiotics exert anti-inflammatory effects and
were first observed in patients with diffuse panbronchioli-
tis. In these patients a tremendous improvement of the 5
year survival rate was observed following treatment with
macrolides [4]. The anti-inflammatory effects of mac-
rolides have been explained by their anti-inflammatory
capabilities which are independent from the antibiotic
effect. These effects have also been studied in human nasal
mucosa and human nasal epithelial cells (HNECs) for
more than 10 years [5,6]. In addition, a double-blind, ran-
domized, placebo-controlled trial on CRS patients treated
with a low dose of roxythromycin, demonstrated clinical
benefit particularly for CRS patients with low levels of IgE
[7].
Fluoroquinolones such as ciprofloxacin are known as
effective antibiotics with excellent activities against
numerous respiratory tract pathogens. They are applied
for the topical treatment of recurrent purulent otitis
media, a common and often bacterial driven inflamma-
tory disease of the middle ear. Moreover, similar to mac-
rolides, fluoroquinolones have been reported to exert
immunomodulatory effects on various cell types [8].
Since these effects have poorly been characterized in CRS,
we examined the effects of ciprofloxacin on the IL-8 syn-
thesis of HNECs stimulated with supernatants of S. aureus
Newman. Thus, the antibiotic effect of ciprofloxacin was
negligible since bacterial supernatants were used for stim-
ulation but not bacteria. Strain Newman was chosen since
it has been shown to produce enterotoxins which have
recently been discussed to play a role in CRSwNP [2]. For
comparative reasons, inhibition experiments with pred-
nisolone and clarithromycin were included.
Materials and methods
Unless declared otherwise, all reagents were purchased
from Sigma (Deisenhofen, Germany).
Inferior turbinate mucosa was gained from two sinus
healthy subjects with no signs of CRS (mean age 42 years)
undergoing septoplasty/septorhinoplasty during routine
surgery at the Department of Otorhinolaryngology of the
University Hospital of Münster, Germany. None of the
patients had undergone sinus surgery previously or
received medical treatment four weeks prior to surgery.
Allergy was excluded by skin-prick test and by RAST.
Informed consent was obtained from all patients and the
study was approved by the ethics committee of the Uni-
versity of Münster. In addition, the authors declare that
they have no competing interests.
Cell culture of HNECs
About 0.1–0.2 g wet tissue obtained from the inferior tur-
binate was dissected for the approach to individual exper-
iments. Subsequently, tissue was washed with phosphate-
buffered saline (PBS) and incubated with trypsin (0.5%)
overnight at 4°C. The epithelial layer was then re-sus-
pended in PBS (pH 7.4). After centrifugation at 1.000 g for
10 minutes, the cells were washed again with PBS, pel-
leted and re-suspended in a serum-free keratinocyte basal
medium (Airway epithelial cell growth medium, AECG
Medium, Promocell, Heidelberg, Germany), supple-
mented with a ready-to addition supplement according to
the manufacturer's recommendation. Penicillin was
applied to a dilution of 200 units/ml medium and strep-
tomycin applied to a dilution of 0.2 μg/ml medium (Bio-
chem, Berlin, Germany). Cells were grown to 80%
confluence and passaged two more times. HNECs were
then split and grown in 12 well plates (each well contain-
ing about 1,8 × 105 cells for a single experiment) to 80%
confluence. The medium was exchanged by serum-free
medium 24 hours prior to stimulation. The epithelial
phenotype of cells was confirmed by staining of epithelial
cells with a monoclonal anti-pan cytokeratin antibody as
previously shown [9].
Stimulation of HNECs
Viability of HNECs as assessed by trypan blue dye exclu-
sion was greater than 95% in all experiments before and
after stimulation.
Experiments were started by performing S. aureus induced
inflammation in HNECs using S. aureus Newman D2C
(ATCC 2590, dilution of 1:10) supernatants. After 12
hours culture supernatants were collected and IL-8 synthe-
sis was quantified by ELISA in double determination
according to the manufacturer's instructions (IL-8 protein
detection range > 3.5 pg/ml, R&D, Wiesbaden, Germany).
Subsequently, serum-free medium was added and HNECs
were coincubated with S. aureus Newman supernatants
and ciprofloxacin (1.5 × 10-5 M, Bayer, Leverkusen, Ger-
many), clarithromycin (10-6 M, Abbot, Wiesbaden, Ger-
many) or prednisolone (10-5  M, Merck, Darmstadt,
Germany) for another 12 hours. Again IL-8 levels were
quantified by ELISA.
Concentrations of inhibors
A dose-response relationship for prednisolone was tested
in previous studies and similar to Wallwork et al. we
found optimal inhibition of IL-8 levels at a concentration
of 10-5 M prednisolone [6,10].
For clarithromycin the concentration of 10-6 M was based
on serum levels of macrolides reached in paranasal sinus
mucosa [11]. In addition, previous studies demonstratedJournal of Inflammation 2008, 5:11 http://www.journal-inflammation.com/content/5/1/11
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decreased IL-8 synthesis by HNECs coincubated with LPS
and erythromycin at a concentration of 10-6 M [5]
Ciprofloxacin was used at a concentration of 1.5 × 10-5 M.
This concentration represents the concentration reached
in tissues and was applied by Ulrich et al. in a study using
primary human epithelial cells derived from nasal polyps
[12,13].
Viability of cells was assessed by trypan blue exclusion test
after 24 hours. Cell viability was greater than 95% in all
experiments.
Statistics
Two-way analysis of variance (ANOVA) was used to calcu-
late differences in IL-8 synthesis as a result of stimulation
with S. aureus Newman. Results were displayed as mean ±
standard deviation. Values of P < .05 were considered to
be significant.
Results
Addition of S. aureus Newman supernatants was associated
with an increase of IL-8 synthesis after 12 hours in all
experiments. However, we observed a significant decrease
of IL-8 synthesis in controls and in controls of antibiotics
and prednisolone that occurred during the second 12
hours (12–24 hours). Moreover, stimulation with S.
aureus Newman alone was associated with an identical
effect: the maximum of IL-8 synthesis was determined
after 12 hours, whereas further stimulation with S. aureus
Newman demonstrated decrease of IL-8 synthesis during
the second 12 hours (12–24 hours). Taken together these
results suggest that a time-dependent decrease of IL-8 syn-
thesis occurred in HNECs which was independent from
any stimulus or inhibitor. As a consequence, the time-
dependent decrease of IL-8 synthesis had to be considered
when analyzing inhibitory effects of ciprofloxacin, clari-
thromycin and prednisolone (fig. 1, 2, 3).
We found that coincubation of HNECs with ciprofloxacin
(1.5 × 10-5 M) resulted in a significant decrease of IL-8
IL-8 synthesis (pg/ml) following coincubation of HNECs with S. aureus supernatants and ciprofloxacin (1.5 × 10-5 M) Figure 1
IL-8 synthesis (pg/ml) following coincubation of HNECs with S. aureus supernatants and ciprofloxacin (1.5 × 10-
5 M). Bars represent means ± standard deviation of three independent experiments. Addition or absence of S. aureus Newman 
supernatants and ciprofloxacin is indicated by "+" and "-". p < 0.05 (*) was considered significant.
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synthesis (p < 0.05). Similarly, addition of clarithromycin
(10-6 M) was associated with a reduction of IL-8 synthesis
although this effect was not significant (p > 0.05). Coin-
cubation of HNECs with supernatants of S. aureus New-
man and prednisolone (10-5 M) resulted in a significant
reduction of IL-8 levels (p < 0.05) (fig. 1, 2, 3).
Discussion
Macrolides have been studied for years and found to exert
immunomodulatory effects that are independent from
their antibiotic effects [4]. Although similar effects have
been reported for the class of fluoroquinolones, their anti-
inflammatory potential on the nasal epithelium has
poorly been characterized [8].
In this study we analyzed the IL-8 response by HNECs
coincubated with S. aureus Newman and ciprofloxacin. In
a previous series of experiments we had already quantified
Eotaxin which is a chemoattractant for eosinophils in
nasal polyps. However, an induction of this chemokine in
HNECs following stimulation with S. aureus supernatants
was not observed.
Since HNECs were stimulated with bacterial supernatants
but not with bacteria, any inhibition of the IL-8 response
by ciprofloxacin could be attributed to immunomodula-
tory effects. We observed that ciprofloxacin significantly
decreased IL-8 synthesis by HNECs. Moreover, inflamma-
tion was induced by S. aureus supernatants in our study
and strain Newman has been shown to produce S. aureus
enterotoxin a (sea) [14]. This is worth mentioning since S.
aureus enterotoxins have been considered to play a role in
CRSwNP [2].
Ciprofloxacin belongs to the fluoroquinolones and dis-
plays excellent activities against numerous respiratory
tract pathogens. It is known to strongly accumulate in
human neutrophils and to easily penetrate epithelial cells.
IL-8 synthesis (pg/ml) following coincubation of HNECs with S. aureus supernatants and clarithromycin (10-6 M) Figure 2
IL-8 synthesis (pg/ml) following coincubation of HNECs with S. aureus supernatants and clarithromycin (10-6 
M). Bars represent means ± standard deviation of three independent experiments. Addition or absence of S. aureus Newman 
supernatants and clarithromycin is indicated by "+" and "-". p < 0.05 (*) was considered significant.
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Moreover it has been demonstrated to exert protective
effects against H. influenzae and Pseudomonas aerugi-
nosa in nasal polyp epithelial cells. In addition, infected
cells could be rescued at a higher rate if ciprofloxacin was
added to the culture [13].
Apart from these bactericidal effects, immunomodulatory
effects of fluoroquinolones have been reported. However,
in vitro exposure of various cells to fluoroquinolones
alone did not exert any measurable immunomodulatory
effect. Stimulation or inhibition of cytokine synthesis has
only been observed when cells were exposed to a stimu-
lant or stress [8]. In HNECs derived from human nasal
polyps levofloxacin was found to down-regulate the syn-
thesis of pro-inflammatory cytokines TNF-α, IFN-γ and IL-
8 [15]. In stimulated airway epithelial cells it was found
that grepafloxacin inhibited the TNF-α stimulated IL-8
synthesis.
Factors that have been associated to regulate the immu-
nomodulatory activity of quinolones include effects on
intracellular cyclic AMP (cAMP) and phosphodiesterases,
transcription factors (NF-κB, AP-1, NF-IL-6, NFAT) and
topoisomerase II interactions [8]. Taken together, qui-
nolones exert their effects on the synthesis of cytokines
through modulation of cellular transcription factors
although the exact events are still unknown and mandates
further studies.
For comparative reasons we also studied the effects of clar-
ithromycin. Addition of 10-6 M clarithromycin was associ-
ated with a decrease of IL-8 synthesis after 12 hours
although inhibition failed to reach significance. However,
previous studies did demonstrate decreased IL-8 synthesis
by HNECs coincubated with LPS and erythromycin even
at a concentration of 10-6 M [5]. Our intention to use a
concentration of clarithromycin of 10-6 M was based on
based on serum levels reached in clinical practice [11]. On
the other hand it has been observed that macrolides pref-
erentially accumulate at sites of inflammation and there-
fore concentrations higher than plasma levels can be
reached.
IL-8 synthesis (pg/ml) following coincubation of HNECs with S. aureus supernatants and prednisolone (10-5 M) Figure 3
IL-8 synthesis (pg/ml) following coincubation of HNECs with S. aureus supernatants and prednisolone (10-5 M). 
Bars represent means ± standard deviation of three independent experiments. Addition or absence of S. aureus Newman super-
natants and prednisolone is indicated by "+" and "-". p < 0.05 (*) was considered significant.
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Apart from a lower concentration of 10-6 M clarithromy-
cin we incubated our cells for 12 hours, whereas in most
other studies cells were incubated for 24 hours at a con-
centration of 10-5 M clarithromycin [5,6]. Wallwork et al.
who used cultures of whole sections of sinus mucosa from
CRS patients found a reduction of IL-8 levels after 24
hours of incubation with 10-5 M clarithromycin [6].
The anti-inflammatory effect of macrolides has been
attributed to inhibition of the activation of NF-κB. Miya-
nohara et al. have evaluated the effects of clarithromycin
on the H. influenzae endotoxin induced expression of IL-
1β and ICAM-1 in HNECs and human nasal fibroblasts.
He found that clarithromycin reduced DNA-binding
activity of NF-κB in HNECs and human nasal fibroblasts
as demonstrated by EMSA [16]. Clinical relevance has
been recently reported by Wallwork et al. who demon-
strated clinical benefit and decrease of IL-8 levels particu-
larly in a subgroup of CRS patients with low levels of IgE
that had been treated with erythromycin [7].
For comparative reasons we included experiments with
prednisolone since it has been well established that ster-
oids are capable to inhibit inflammatory reactions by the
reduction of cytokines such as IL-8 [17]. We found
decreased IL-8 synthesis by HNECs following coincuba-
tion with Newman supernatants and prednisolone. How-
ever, failure of IL-8 reduction by prednisolone has been
reported in CRS, too [18].
Conclusion
Taken together, we demonstrated anti-inflammatory
effects of ciprofloxacin on the IL-8 synthesis in S. aureus
Newman driven nasal inflammation in vitro. These anti-
inflammatory effects were comparable to those of pred-
nisolone and clarithromycin. Fluoroquinolones may
therefore represent an alternative target to reduce inflam-
matory mediators in the nasal mucosa. However, further
studies are necessary for a detailed understanding of the
immunomodulatory potential of fluoroquinolones.
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